Amy Strelzer Manasevit Research Program
The Amy Strelzer Manasevit Research Program for the Study of Post-Transplant Complications (Amy Research Program) is one of the largest and most coveted grants in the field of transplantation. The grant supports the research endeavors of scientists and clinicians early in their careers. Its goal is to launch these young investigators on a life-long journey to discover solutions to potentially life-threatening post-transplant complications such as infection or graft-versus-host disease.
The emphasis on early support attracts new talent to the field and encourages the researchers to focus on these complications throughout their careers. Amy Scholars receive a maximum of $240,000 divided over three years from the Be The Match Foundation®. This crucial funding enables the researchers to continue with their projects consistently without having to stop and apply for further financial support.
The 2016 application period has closed.
2016 Requirements and Conditions of the Amy Strelzer Manasevit Research Program
- The research proposal must address complications arising after allogeneic hematopoietic cell transplantation. Post-transplant complications are defined as acute and late complications, including relapse.
- Proposals may describe either clinical or pre-clinical investigations. Clinical investigations include observational human research, prospective interventional clinical trials in humans, and ancillary laboratory studies performed in conjunction with a human prospective clinical trial. Pre-clinical investigations include laboratory-based human or animal studies designed to test the mechanisms, safety, and efficacy of an intervention prior to or in conjunction with its application in humans.
- Two awards, one for a clinical proposal and one for a pre-clinical proposal, will be made for a maximum of $240,000 in support over three years. Payments will be made in segments; upon receipt of grant, at six month reporting milestones and upon receipt of final report.
- Applicants must have received a doctoral degree (M.D., Ph.D., D.O. or equivalent) within the past twelve years (January 1, 2004 or later) in a field pertinent to the award. If the applicant has more than one relevant doctoral degree, the date the most recent relevant doctoral degree was obtained will be used to determine eligibility. If credentials for eligibility are uncertain, please email Roberta King at email@example.com. Applicants must hold a position in an approved U.S. facility and must be employed by an institution in the U.S. for the duration of the award. Applicants must be U.S. citizens, permanent residents or foreign citizens holding a valid U.S. visa.
- The Awards Committee will select two scholars, one for a clinical proposal and one for a pre-clinical proposal, for the funding period July 1, 2016 through June 30, 2019. Awardees will be announced at the 2016 BMT Tandem Meetings in Honolulu, Hawaii, February 18-22, 2016.
The program was established in 1997 to honor the memory of Amy Strelzer Manasevit. A vibrant young mother of two, Amy was diagnosed with multiple myeloma in 1993. After receiving a successful marrow transplant, she succumbed to pneumonia and passed away six weeks after returning home. Manasevit’s family and friends partnered with NMDP/Be The Match to establish the research program in the hope they could prevent other families from losing their loved ones.
To date, Be The Match Foundation has supported 25 scholars and 13 post-doctoral fellows. The Amy Scholars were initially awarded more than $6 million and have leveraged their research to secure an additional $35 million in research funding.
Contact us for more information about the Amy Strelzer Manasevit Research Program.